Compare LENZ & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | RCMT |
|---|---|---|
| Founded | 2019 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.8M | 196.0M |
| IPO Year | 2021 | 1997 |
| Metric | LENZ | RCMT |
|---|---|---|
| Price | $5.91 | $26.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.00 | $36.00 |
| AVG Volume (30 Days) | ★ 556.6K | 67.4K |
| Earning Date | 05-06-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.38 |
| EPS | N/A | ★ 0.52 |
| Revenue | $19,088,000.00 | ★ $186,737,000.00 |
| Revenue This Year | $50.42 | $11.89 |
| Revenue Next Year | $197.16 | $12.46 |
| P/E Ratio | ★ N/A | $49.44 |
| Revenue Growth | N/A | ★ 5.83 |
| 52 Week Low | $6.29 | $17.26 |
| 52 Week High | $50.19 | $32.50 |
| Indicator | LENZ | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 29.43 | 60.27 |
| Support Level | N/A | $26.23 |
| Resistance Level | $10.42 | $27.62 |
| Average True Range (ATR) | 0.43 | 1.06 |
| MACD | -0.02 | 0.49 |
| Stochastic Oscillator | 3.26 | 86.39 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.